ILLUMINA INC (ILMN) Stock Fundamental Analysis
USA - NASDAQ:ILMN - US4523271090 - Common Stock
121.72 USD
-0.18 (-0.15%)
121.72 USD
0 (0%)
ILMN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While ILMN has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on ILMN. This makes ILMN very considerable for value investing!
1. Profitability
1.1 Basic Checks
ILMN had positive earnings in the past year.
ILMN had a positive operating cash flow in the past year.
In multiple years ILMN reported negative net income over the last 5 years.
ILMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
ILMN has a better Return On Assets (20.67%) than 94.83% of its industry peers.
ILMN has a better Return On Equity (55.71%) than 96.55% of its industry peers.
The Return On Invested Capital of ILMN (15.46%) is better than 91.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROIC | 15.46% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 29.37%, ILMN belongs to the top of the industry, outperforming 98.28% of the companies in the same industry.
ILMN has a better Operating Margin (21.13%) than 87.93% of its industry peers.
In the last couple of years the Operating Margin of ILMN has declined.
Looking at the Gross Margin, with a value of 67.09%, ILMN belongs to the top of the industry, outperforming 91.38% of the companies in the same industry.
In the last couple of years the Gross Margin of ILMN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.13% | ||
| PM (TTM) | 29.37% | ||
| GM | 67.09% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
ILMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ILMN has about the same amout of shares outstanding than it did 1 year ago.
ILMN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ILMN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.16 indicates that ILMN is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.16, ILMN is doing good in the industry, outperforming 79.31% of the companies in the same industry.
ILMN has a debt to FCF ratio of 1.93. This is a very positive value and a sign of high solvency as it would only need 1.93 years to pay back of all of its debts.
ILMN has a better Debt to FCF ratio (1.93) than 87.93% of its industry peers.
ILMN has a Debt/Equity ratio of 0.66. This is a neutral value indicating ILMN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, ILMN is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for ILMN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Altman-Z | 4.16 |
ROIC/WACC1.53
WACC10.13%
2.3 Liquidity
A Current Ratio of 1.81 indicates that ILMN should not have too much problems paying its short term obligations.
ILMN has a worse Current ratio (1.81) than 62.07% of its industry peers.
ILMN has a Quick Ratio of 1.41. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.41, ILMN is not doing good in the industry: 63.79% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
ILMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.02%, which is quite impressive.
The earnings per share for ILMN have been decreasing by -17.93% on average. This is quite bad
Looking at the last year, ILMN shows a decrease in Revenue. The Revenue has decreased by -2.32% in the last year.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
The Earnings Per Share is expected to grow by 24.99% on average over the next years. This is a very strong growth
Based on estimates for the next years, ILMN will show a small growth in Revenue. The Revenue will grow by 3.93% on average per year.
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.99%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 27.92, which means the current valuation is very expensive for ILMN.
ILMN's Price/Earnings ratio is a bit cheaper when compared to the industry. ILMN is cheaper than 74.14% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.28. ILMN is around the same levels.
A Price/Forward Earnings ratio of 24.07 indicates a rather expensive valuation of ILMN.
Based on the Price/Forward Earnings ratio, ILMN is valued a bit cheaper than 79.31% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.61, ILMN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.92 | ||
| Fwd PE | 24.07 |
4.2 Price Multiples
86.21% of the companies in the same industry are more expensive than ILMN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ILMN is valued cheaply inside the industry as 87.93% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.15 | ||
| EV/EBITDA | 16.33 |
4.3 Compensation for Growth
ILMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ILMN has a very decent profitability rating, which may justify a higher PE ratio.
ILMN's earnings are expected to grow with 33.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y43.68%
EPS Next 3Y33.01%
5. Dividend
5.1 Amount
ILMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
121.72
-0.18 (-0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.96%
Inst Owner Change-0.63%
Ins Owners0.18%
Ins Owner Change2.4%
Market Cap18.71B
Revenue(TTM)4.29B
Net Income(TTM)1.26B
Analysts72.86
Price Target114.15 (-6.22%)
Short Float %4.35%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.3%
Min EPS beat(2)1.33%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-7.76%
Max EPS beat(4)26.88%
EPS beat(8)6
Avg EPS beat(8)115.88%
EPS beat(12)10
Avg EPS beat(12)231.91%
EPS beat(16)13
Avg EPS beat(16)178.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.63%
Revenue beat(12)4
Avg Revenue beat(12)-0.69%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)0.26%
PT rev (3m)-1.64%
EPS NQ rev (1m)-0.46%
EPS NQ rev (3m)0.5%
EPS NY rev (1m)2.9%
EPS NY rev (3m)9.83%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0.35%
Revenue NY rev (3m)1.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.92 | ||
| Fwd PE | 24.07 | ||
| P/S | 4.37 | ||
| P/FCF | 18.15 | ||
| P/OCF | 16.21 | ||
| P/B | 8.29 | ||
| P/tB | 20.63 | ||
| EV/EBITDA | 16.33 |
EPS(TTM)4.36
EY3.58%
EPS(NY)5.06
Fwd EY4.16%
FCF(TTM)6.71
FCFY5.51%
OCF(TTM)7.51
OCFY6.17%
SpS27.87
BVpS14.69
TBVpS5.9
PEG (NY)0.3
PEG (5Y)N/A
Graham Number37.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROCE | 19.56% | ||
| ROIC | 15.46% | ||
| ROICexc | 20.6% | ||
| ROICexgc | 33.72% | ||
| OM | 21.13% | ||
| PM (TTM) | 29.37% | ||
| GM | 67.09% | ||
| FCFM | 24.07% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | 44.24% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.55% | ||
| Profit Quality | 81.96% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 4.16 |
F-Score6
WACC10.13%
ROIC/WACC1.53
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y93.48%
EPS Next 2Y43.68%
EPS Next 3Y33.01%
EPS Next 5Y24.99%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-1.07%
Revenue Next 2Y0.57%
Revenue Next 3Y2.22%
Revenue Next 5Y3.93%
EBIT growth 1Y275.52%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.85%
EBIT Next 3Y15.15%
EBIT Next 5Y16.22%
FCF growth 1Y560.27%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y449.52%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILMN FAQ
Can you provide the ChartMill fundamental rating for ILLUMINA INC?
ChartMill assigns a fundamental rating of 6 / 10 to ILMN.
What is the valuation status for ILMN stock?
ChartMill assigns a valuation rating of 7 / 10 to ILLUMINA INC (ILMN). This can be considered as Undervalued.
How profitable is ILLUMINA INC (ILMN) stock?
ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.
How financially healthy is ILLUMINA INC?
The financial health rating of ILLUMINA INC (ILMN) is 6 / 10.
Can you provide the expected EPS growth for ILMN stock?
The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 93.48% in the next year.